Prompt implementation of hemodynamic support may mitigate the impact of procedural hypotension on MACE.Д¬oronary artery calcium is a marker of advanced coronary artery disease and is a predictor of adverse clinical outcomes including stroke and myocardial infarction. In-hospital major adverse cardiac events (MACE) and mortality were not increased by procedural hypotension. Rotational atherectomy can be performed without hemodynamic support in most cases.Д«ailout hemodynamic support was more common in patients with LVEF в‰¤30%. Retrospective analysis of rotational atherectomy with reduced left ventricular ejection fraction (LVEF).

If indicated, prompt implementation of hemodynamic support mitigated any impact of procedural hypotension on in-hospital MACE and mortality. RA can be effectively utilized in patients with severely reduced LVEF however, these patients are at increased risk of prolonged procedural hypotension requiring bailout hemodynamic support.

Otherwise, no significant differences in in-hospital MACE, or mortality were observed. Combined subgroup analysis also demonstrated statistical significance 11.1% vs 1.8% ( PВ =вЂЇ0.0324) in the в‰¤30% vs >30% subgroups. Analysis revealed a significant trend as bailout hemodynamic support was required in 11.1% vs 2.4% ( PВ =вЂЇ0.1551) in the в‰¤30% vs 31вЂ“50% and 11.1% vs 1.4% ( PВ =вЂЇ0.0416) in the в‰¤30% vs >50% subgroups. Bailout hemodynamic support was required in four cases. Statistical analysis included 18, 42, and 71 patients with LVEF в‰¤30%, 31вЂ“50%, and >50%, respectively. The incidence of procedural hypotension, major adverse cardiac events (MACE), and mortality were recorded. Patients were categorized into three groups: LVEF в‰¤30%, LVEF 31вЂ“50%, and LVEF >50%. We retrospectively identified 131 consecutive patients undergoing RA without elective PCAD over a three-year period. There is limited data examining the safety and efficacy of rotational atherectomy (RA) without hemodynamic support in patients with reduced left ventricular ejection fraction (LVEF).

Elective insertion of a percutaneous circulatory assist device (PCAD) in high-risk patients is considered a reasonable adjunct to percutaneous coronary intervention (PCI).

How to use pcad 2006 reports